publication date: Sep. 12, 2014

html SU2C.html

By Matthew Bin Han Ong

Stand Up To Cancer, a non-profit cancer group that conducts televised fundraising events, raised over $109 million last weekend.

The group’s triumphant Sept. 7 press release, awash with pictures of participating Hollywood celebrities, hailed this achievement. However, the group also became a target for criticism for failing to mention that three of its high-level donors have ties to the tobacco industry.

SU2C officials aren’t denying the connection.

These donors—called “partners” in SU2C parlance—promote cancer through the sale of tobacco products, said Alan Blum, director of the University of Alabama Center for the Study of Tobacco and Society and the Gerald Leon Wallace, MD, Endowed Chair in Medicine at the University of Alabama School of Medicine.

“It is shameful that after decades of efforts to end the leading cause of cancer, the organizers of this cause would welcome the participation of manufacturers, promoters and sellers of cigarettes,” said Blum, past editor of the Medical Journal of Australia and the New York State Journal of Medicine, and former head of the physicians’ anti-smoking group Doctors Ought to Care.

The trio identified by Blum is: SIEMENS, Safeway Foundation and the Steve Tisch Foundation.

Stand Up To Cancer has received over $260 million in pledged funds since its inception in 2008.

SU2C’s most recent telethon aired Sept. 5 on major television networks in over 170 countries, featuring celebrities such as Robert Downey Jr., Gwyneth Paltrow, Pierce Brosnan and others.

One hundred percent of donations received from the public go to … Continue reading 40-34 Tobacco Interests Contribute a Portion Of the $109 Million Raised by SU2C

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.